pI: 6.0885 |
Length (AA): 489 |
MW (Da): 52759 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 5 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
101 | 218 | 1nvj (B) | 22 | 127 | 35.00 | 0 | 0.98 | 0.71 | 0.21 |
102 | 206 | 2mqa (A) | 20 | 124 | 15.00 | 0 | 0.03 | 0.404924 | -0.84 |
148 | 254 | 4zch (A) | 16 | 125 | 16.00 | 0 | 0.06 | 0.384014 | -0.27 |
279 | 418 | 5mpo (C) | 42 | 169 | 32.00 | 0 | 1 | 0.646499 | -0.62 |
297 | 420 | 2omd (A) | 13 | 135 | 28.00 | 0 | 0.91 | 0.628079 | -0.14 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | ME49 Oocyst. | Fritz HM |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | VEG Tachyzoite, ME49 Tachyzoite, ME49 Bradyzoite. | Gregory Sibley/Greg |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | ME49 merozoite. | Hehl AB |
Hehl AB | Asexual expansion of Toxoplasma gondii merozoites is distinct from tachyzoites and entails expression of non-overlapping gene families to attach, invade, and replicate within feline enterocytes. |
Gregory | ToxoDB |
Sibley/Greg | ToxoDB |
Fritz HM | Transcriptomic analysis of toxoplasma development reveals many novel functions and structures specific to sporozoites and oocysts. |
Ortholog group members (OG5_128296)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT2G43760 | Molybdopterin synthase catalytic subunit |
Caenorhabditis elegans | CELE_T27A3.6 | Protein T27A3.6 |
Dictyostelium discoideum | DDB_G0271864 | molybdenum cofactor synthesis protein 2 large subunit |
Drosophila melanogaster | Dmel_CG10238 | Molybdenum cofactor synthesis 2 |
Escherichia coli | b0785 | molybdopterin synthase, large subunit |
Homo sapiens | ENSG00000164172 | molybdenum cofactor synthesis 2 |
Loa Loa (eye worm) | LOAG_00832 | hypothetical protein |
Mus musculus | ENSMUSG00000015536 | molybdenum cofactor synthesis 2 |
Mycobacterium tuberculosis | Rv3119 | Probable molybdenum cofactor biosynthesis protein E MoaE1 (molybdopterin converting factor large subunit) (molybdopterin [MPT] c |
Mycobacterium tuberculosis | Rv0866 | Probable molybdenum cofactor biosynthesis protein E2 MoaE2 (molybdopterin converting factor large subunit) (molybdopterin [MPT] |
Mycobacterium tuberculosis | Rv3323c | Probable MoaD-MoaE fusion protein MoaX |
Mycobacterium ulcerans | MUL_0284 | molybdenum cofactor biosynthesis protein E2 MoaE2 |
Oryza sativa | 4328260 | Os02g0140300 |
Onchocerca volvulus | OVOC254 | Molybdopterin synthase catalytic subunit homolog |
Schistosoma japonicum | Sjp_0306770 | ko:K03635 molybdenum cofactor biosynthesis protein E, putative |
Schmidtea mediterranea | mk4.019893.00 | Molybdopterin synthase catalytic subunit |
Schmidtea mediterranea | mk4.001953.02 | Molybdopterin synthase catalytic subunit |
Toxoplasma gondii | TGME49_273350 | molybdopterin converting factor, subunit 2 protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
mtu882 | Mycobacterium tuberculosis | non-essential | nmpdr |
mtu3383 | Mycobacterium tuberculosis | non-essential | nmpdr |
b0785 | Escherichia coli | non-essential | goodall |
TGME49_273350 this record | Toxoplasma gondii | Probably non-essential | sidik |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.